Effects of I.C.V. administration of ethylcholine aziridinium (AF64A) on the central glutamatergic nervous systems in rats

Archives of Pharmacal Research

Volumn 20, Issue 1, 1997, Pages 39-45

  Ma, Young ^a   Lim, Dong Koo ^a  

^a Chonnam National University   (South Korea)

Author keywords

Ethylcholine aziridinium; Glutamate; Glutaminase; Glutamine synthetase; NMDA receptors

Indexed keywords

EID: 3342905794     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02974040     Document Type: Article

References (40)

1. Abe, E., Murai, S., Masuda, Y., Saito, H. and Itoh, T., Reversal by 3,3′,5-triido-L-thyronine of the working memory deficit, and the decrease in acetylcholine, glutamate and γ-aminobutyric acid induced by ethylcholine aziridinium ion in mice. Naunyn-Schmiedeberg's Arch. Pharmacol., 346, 238-242 (1992).
2. Bartus, R. T., Dean, R. L., Beer, B. and Lippa, A. S., The cholinergic hypothesis of geriatric memory function. Sci., 217, 408-417 (1982).
3. Bergmeyer, H. U., Methods of enzymatic analysis. Verlag Chemie Weinheim Academic Press, Inc. New York and London, 2, pp. 650-656, 1974.
4. Chrobak, J. J., Hanin, I., Schmechel, D. E. and Walsh, T. J., AF64A induced working memory impairment: behavioral, neurochemical and histological correlates. Brain Res., 463, 107-117 (1988).
5. Colye, J. T., Price, D. and DeLong, M., Anatomy of cholinergic projections to cerebral cortex: implications for the pathophysiology of senile dementia of the Alzheimer's type. Trend in Pharmacol., 5, 90-94 (1984).
6. Cowburn, R., Hardy, J., Roberts, P. and Briggs, R., Presynaptic and postsynaptic glutamatergic function in Alzheimer' disease. Neurosci. Lett., 86, 109-113 (1988).
7. Dijk, S. N., Francis, P. T., Stratmann, G. C. and Bowen, D. M., Cholinomimetics increase glutamate outflow via an action on the corticostriatal pathway: implications for Alzheimer's disease. J. Neurochem., 65, 2165-2169 (1995).
8. Ebert, B., Wong, E. H. F. and Krogsgaard-Larsen, P., Identification of a novel NMDA receptor in rat cerebellum. Eur. J. Pharmacol.-Mol. Pharmacol., Section 208, 49-52 (1991).
9. Ellison, D. W., Beal, M. F. and Martin, J. B., Amino acid neurotransmitters in postmortem human brain analyzed by high performance liquid chromatography with electrochemical detection. J. Neurosci. Methods., 19, 305-315 (1987).
10. Foster, A. C. and Wong, E. H. F., The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. Br. J. Pharmacol., 91, 403-412 (1987).
11. 3H-DOPA in various regions of the rat. J. Neurochem., 13, 655-669 (1966).
12. 3H]Norepinephrine release from rat cortical slices. J. Pharmacol. Exp. Therpeutics., 264, 282-288 (1993).
13. Greenamyre, J. T. and Maragos, W. F., Neurotransmitter receptors in Alzheimer's disease. Cerebrovasc. Brain Metab. Rev., 5, 61-94 (1993).
14. 3H]glutamate binding. J. Neurochem., 48, 543-551 (1987).
15. Hanin, I., Mantione, C. R. and Fisher, A., AF64A-induced neurotoxicity: a potential animal model in Alzheimer's disease, In S. Corkin, K. L. Davis, L. H. Growdon, E. Usdin, and R. J. Wurtman (Eds.). Alzheimer's Disease: A report of progress (Aging). Raven, New York, 19, 267-270 (1982).
16. Hortnagl, H., Berger, M. L., Reither, H. and Hornykiewicz, O., Cholinergic deficit induced by ethylcholine aziridinium (AF64A) in rat hippocampus: Effect on glutamatergic systems. Naunyn-Schmiedeberg's Arch. Pharmacol., 344, 213-219 (1991).
17. Kugler, P., Enzymes involved in glutamatergic and GABAergic neurotransmission. Int. Rev. Cytol., 147, 285-336 (1993).
18. Leventer, S. M., Wulfert, E. and Hanin, I., Time course of ethylcholine aziridinium ion (AF64A)-induced cholinotoxicity in vivo. NeuroPharmarcol., 26, 361-365 (1987).
19. Lim, D. K., Ma, Y. and Yi, E. Y., Effects of intracerebroventricular administration of ethylcholine aziridinium (AF64A) on dopaminergic nervous systems. Arch. Pharm. Res., 19, 23-29 (1996).
20. Lim, D. K., Wee, S. M., Ma, Y. and Yi, E. Y., Effects of ethylcholine aziridinium, scopolamine, and morphine on learning behaviors in Morris water maze. Arch. Pharm. Res., 18, 346-350 (1995).
21. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J., Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275 (1951).
22. Mantione, C. R., Zigmond, M. J., Fisher, A. and Hanin, I., Selective presynaptic cholinergic neurotoxicity following intrahippocampal AF64A injection in rats. J. Neutochem., 41, 251-255 (1983).
23. Maragos, W. F., Greenamyre, J. T., Penney, J. B. and Young, A. B., Glutamate dysfunction in Alzheimer's disease: An hypothesis. Trends Neurosci., 10, 65-68 (1987).
24. 2 muscarinic receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Sci., 228, 1115-1117 (1985).
25. Meana, J. J., Johansson, B., Herrera-Marschitz, M., O'Connor, W. T., Goiny, M., Parkinson, F. E., Fredholm, B. B. and Ungerstedt, U., Effect of the neurotoxin AF64A on intrinsic and extrinsic neuronal systems of rat neostriatum measured by in vivo microdialysis. Brain Res., 596, 65-72 (1992).
26. Monaghan, D. T. and Cotman, C. W., Assessing glutamatergic involvement in stone maze performance. J. Neurosci., 5, 2909-2919 (1985).
27. Myhrer, T., Animal models of Alzheimer's disease: Glutamatergic denervation as an alternative approach to cholinergic denervation. Neurosci. Biobehav. Rev., 17, 195-202 (1993).
28. Nakahara, N., Igo, Y., Mizobe, F. and Kawanishi, G., Effects of intracerebroventricular injection of AF64A on learning behaviors in rats. Jpn. J. Pharmacol., 48, 121-130 (1988).
29. Nicolls, D. and Attwell, D., The release and uptake of excitatory amino acids. TIPS, 11, 462-468 (1990).
30. Palmer, A. M. and Gershon, S., Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic? FASEB J., 4, 2745-2752 (1990).
31. Patel, A. J., Hunt, A., Gordon, R. D. and Balazs, R., The activities in different neural cell types of certain enzymes associated with the metabolic compartmentation glutamate. Developmental Brain Res., 4, 3-11 (1982).
32. Paxinos, G. and Watson, C., The brain in stereotaxic coordinates. Academic Press, New York, 1986.
33. (15,3R) attenuate learning in a morris water maze paradigm. Neurosci. Lett., 178, 43-46 (1994).
34. Ransmayr, G., Cervera, P., Hirsch, E. C., Fisher, W. and Agid, Y., Alzheimer's disease : Is the decrease of the cholinergic innervation of the hippocampus related to intrinsic hippocampal pathology? Neurosci., 47, 843-851 (1992).
35. Shoup, R. E., Allison, L. A. and Mayer, G. S., o-Phthalaldehyde derivatives of amines for high-speed liquid chromatography/electrochemistry. Analytical Chem., 56, 1089-1096 (1984).
36. Sims, N. R., Bowen, D. M., Allen, S. J., Smith, C. C. T., Neary, D., Thomas, D. J. and Davison, A. N., Presynaptic cholinergic dysfunction in patients with dementia. J. Neurochem., 40, 503-509 (1983).
37. Staubli, U., Rogers, G. and Lynch, G., Facilitation of glutamate receptors enhances memory. Proc. Natl. Acad Sci., 91, 777-781 (1994).
38. Ulas, J., Weihmuller, F. B., Brunner, L. C., Joyce, J. N., Marshall, J. F. and Cotman, C. W., Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study. J. Neurosci., 14, 6317-6324 (1994).
39. Watkins, J. C., Krogsgaard-Larsen, P. and Honore, T., Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. TIPS, 11, 25-33 (1990).
40. Young, A. B. and Fagg, G. E., Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches. TIPS, 11, 126-133 (1990).